Literatur
Aprikian AG, Herr HW, Bajorin DF, Bosl GJ (1994) Resection of postchemotherapy residual masses and limited retroperitoneal lympha-denectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Cancer 74: 1329–1334
Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP (1995) Complications of post-chemotherapy retroperitoneal lymph node dissection. J Urol 153: 976–980
Bender H, Schomburg A, Albers P, Ruhlmann J, Biersack HJ (1997) Possible role of FDG-PET in the evaluation of urologic malignancies. Anticancer Res 17: 1655–1660
Herr HW, Sheinfeld J, Puc HC, Heeland R, Bajorin DF, Mencel P, Bosl GJ, Motzer RJ (1997) Surgery for a post-chemotherapy residual mass in seminoma. J Urol 157: 860–862
Hofmockel G, Gruss A, Theiss M (1996) Chemotherapy in advanced seminoma and the role of postcytostatic retroperitoneal lymph node dissection. Urol Int 57: 38–42
Jaeger N, Weissbach L, Bussar-Maatz R (1994) Size and status of metastases after inductive chemotherapy of germ-cell tumors. Indication for salvage operation. World J Urol 12: 196–199
Matsuyama H, Yamamoto N, Sakatoku J, Suga A, Hayashida S, Kamiryo Y, Nagata K, Naito K (1994) Predictive factors for the histologic nature of residual tumor mass after chemotherapy in patients with advanced testicular cancer. Urology 44: 392–398
Puc HS, Heelan R, Mazumdar M, Herr H, Scheinfeld J, Vlamis V, Bajorin DF, Bosl GJ, Mencel P, Motzer RJ (1996) Management of residual mass in advanced seminoma: results and recommendations form the Memorial Sloan-Kettering Cancer Center. J Clin Oncol 14: 454–460
Stephens AW, Gonin R, Hutchins GD, Einhorn LH (1996) Positron emission tomography evaluation of residual radiographie abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol 14: 1637–1641
Steyerberg EW, Keizer HJ, Fossa SD, Sleijfer DT, Toner GC, Schraffordt-Koops H, Mulders PF, Messemer JE, Ney K, Donohue JP et al (1995) Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol 13: 1177–1187
Weißbach L, Bamberg M, Scholl HJ (1997) Interdisziplinäre Konsensuskonferenz zur „Diagnostik und Therapie von Hodentumoren“. Urologe [A] 36: 362–368
Wood DP Jr, Herr HW, Heller G, Vlamis V, Sogani PC, Motzer RJ, Fair WR, Bosl GJ (1992) Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol 148: 1812–1815
Wood DP Jr, Herr HW, Motzer RJ, Reuter V, Sogani PC, Morse MJ, Bosl GJ (1992) Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer 70: 2354–2357
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Albers, P., Müller, S.C. Indikation zur Residualtumorresektion bei Hodentumoren. Der Urologe B 37, 455–456 (1997). https://doi.org/10.1007/s001310050109
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001310050109